Bayer Faces Billions in Payouts
These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
Chemical company Monsanto — owned by Bayer — was found liable this week by a jury for harm caused to students and parents at ...
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the ...
Bayer said Thursday it has acquired camelina germplasm, intellectual property, and materials from Smart Earth Camelina Corp. with the goal of boosting the seed and chemical giant's leadership in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback